Why is ORPH.IR stock trading with high pre-market volume?

ORPH.IR stock shows elevated pre-market volume (**15,112.00**) likely from a concentrated block order or fresh bulletin. High relative volume (**78.71**) can signal news, a technical breakout test, or liquidity-seeking activity. Verify any company release before trading.

What valuation metrics matter for ORPH.IR stock?

Key metrics include P/E **7.73**, price-to-book **1.84**, current ratio **1.89**, and ROE **26.97%**. These show a cheaply valued biotech with moderate leverage, but confirm EPS and market-cap data from official filings.

How should short-term traders approach ORPH.IR stock after the volume spike?

Short-term traders should use limit orders, confirm sustained regular-session volume, set a stop near **€0.13**, and scale out on strength. Check exchange notices and the company site for catalyst confirmation before increasing exposure.

What does the Meyka AI forecast say about ORPH.IR stock?

Meyka AI's forecast model projects a 12-month target of **€0.22** for ORPH.IR stock versus the current **€0.14**, implying **57.14%** upside. Forecasts are model-based projections and not guarantees.

EU Stocks

Pre-Mkt spike ORPH.IR Open Orphan €0.14 EURONEXT 05/02/2026: watch liquidity

ByHuzaifa Zahoor February 5, 2026February 5, 2026

A pre-market volume spike has pushed ORPH.IR stock into focus at €0.14 on 05/02/2026. Trade volume is elevated at 15,112.00 versus an average of 192.00, a relative volume of 78.71. This jump in activity on EURONEXT in Europe occurs around a price sitting near the 50-day average €0.14 and well below the 200-day average €0.17. We summarise why the volume matters, what price action and valuation say, and where short-term traders should watch liquidity and catalysts